ChromaDex Corp. (CDXC)

[Milarepa]

We are for sure. Whether Elysium is depends on whether its investors see a plausible end-game. My view is that they have a perfectly good business, if they would confine themselves to selling supplements that they have a legal right to sell, of which they are about a million. Their apparent disinterest in that, I think, will bring things to a head with their investors sooner rather than later.